Bright White: Organic acids prevent decomposition and discoloration of an antitumor agent
Would you want to swallow a tablet that’s yellow rather than its usual white? Would this effect be harmless and would the drug still be efficient? Researchers in India have now described an approach to maintaining the color and activity of an antitumor agent. As they report in Chemistry - An Asian Journal, acids can protect powders of the drug from discoloration and loss of activity.
The anticancer agent temozolomide is stable in the presence of acid, but when white tablets of the drug are stored for an extended period of time, they turn light pink or tan. This discoloration is indicative of degradation by water in neutral or basic conditions, which lowers the effectiveness of the drug, and has the potential to disconcert patients.
Ashwini Nangia and co-workers at the University of Hyderabad, India, have developed a method to increase the chemical stability of temozolomide and prevent discoloration. They made solids comprising temozolomide that is intimately mixed with an acid, forming so-called cocrystals. The acid effectively protects the drug from degradation, and the cocrystals showed no signs of discoloration for over six months, even in humid air. As acids, they chose safe organic acids such as acetic acid (found in vinegar), succinic acid (a fermentation byproduct) and oxalic acid (found in rhubarb). Preliminary assessment of the pharmacological properties of the cocrystals indicates that especially those incorporating succinic acid and oxalic acid could be suitable for use in formulation development.
Fluorinated structures make up more than 20 percent of modern drugs, but benign and fast fluorination schemes are scarce. In a study scientists have now combined dynamic kinetic resolution and nucleophilic fluorination for the asymmetric synthesis of florfenicol, a veterinary antibiotic. Af ... more
For efficient cancer therapy with few side effects, the active drug should selectively attain high concentration in the tumor. Scientists have now introduced a new approach, in which two synergistic drug components are combined into a dimer. This dimer can be incorporated into polymeric nan ... more
Combinatorial libraries are a key component of the chemist's toolkit for ligand screening. Dynamic combinatorial libraries add a new dimension by interlinking synthesis and screening. Now, British scientists have developed a dynamic combinatorial library for the screening of supramolecular ... more
As medicine and pharmacology investigate nanoscale processes, it has become increasingly important to identify and characterize different molecules. Raman spectroscopy, a technique that leverages the scattering of laser light to identify molecules, has a limited capacity to detect molecules ... more